bioRxivMolecular BiologyPreprint
Insight into the scaffolding function of USP18 from a high resolution cryo-EM structure of STAT2-USP18-ISG15 ternary complex
Kevin W. HuynhiD, Rachel PlumbiD, David R. Healy, Veronica JovéiD, Erik C. Ralph, Chiachin Wilson Lee, Heather Wheeler, Kymberly K. Levine, Zhen Huang, Kimberly F. FennelliD, Richard A. Corpina, Timothy K. CraigiD, Paul D. WesiD, Paula M. LoriaiD, Monica SchenoneiD, Seungil HaniD, Feng Wang, Huixian WuiD, Masaya YamaguchiiD
Abstract
USP18 is a primary negative regulator of the type I interferon (IFN-I) signaling which regulates hundreds of IFN-stimulated genes for viral protection and anti-cancer immunity. USP18 plays dual roles in the IFN-I signaling: 1) deubiquitinase enzymatic function which cleaves ISG15 from its substrates and 2) scaffolding function through forming a complex with STAT2 to suppress IFN-I signaling. Targeting the scaffolding function of USP18, instead of its enzyme activity, is crucial for reducing cancer cell fitness and boosting anti-tumor immunity. However, the molecular basis of USP18s scaffolding function remains unclear due to the lack of structural information. Here, using a fusion tag strategy, we captured the transient USP18-STAT2 complex and determined a ternary complex structure of STAT2-USP18-ISG15 at 3.05 [A] resolution by cryogenic electron microscopy (cryo-EM) that delineated detailed USP18-STAT2 interactions. Remarkably, the ternary complex impairs USP18s enzymatic function by STAT2-mediated disruption of its catalytic triad. Structural analysis and mutagenesis identify specific USP18 point mutations, facilitating further investigation into the role of USP18 in IFN-I signaling. Taken together, our findings suggest that USP18s scaffolding function could present an untapped opportunity for cancer therapy.
- Citations
- 1
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Dissecting the interactions of the ISG15-USP18-STAT2 inhibitory complex
Jessica C Rowe, Yi Min Ng, … Kirby N. Swatek·bioRxiv·Mar 27, 2026
- Human USP18 protects diverse cancer lineages from Type I Interferon independently of its canonical catalytic function
V. Jove, H. Wheeler, … F. Wang·bioRxiv·Mar 23, 2023
- ISGylation-independent protection of cell growth by USP18 following interferon stimulation
A. Clancy, E. V. Rusilowicz-Jones, … M. J. Clague·bioRxiv·Jul 21, 2023
- Mechanisms of USP18 deISGylation revealed by comparative analysis with its human paralog USP41
Thomas Bonacci, Derek L. Bolhuis, … Michael J. Emanuele·Journal of Biological ChemistryPeer-reviewed·May 26, 2025
- Deep analysis of the USP18-dependent ISGylome and proteome unveils important roles for USP18 in tumour cell antigenicity and radiosensitivity
A. Pinto-Fernandez, M. Salio, … B. M. Kessler·bioRxiv·Mar 31, 2020
- A co-opted ISG15-USP18 binding mechanism normally reserved for deISGylation controls type I IFN signalling
A. Vasou, K. Nightingale, … D. J. Hughes·bioRxiv·Jun 1, 2021